4.6

CiteScore

2.2

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Joshua M. Mutiso, John C. Macharia, Michael M. Gicheru. A review of adjuvants for Leishmania vaccine candidates[J]. The Journal of Biomedical Research, 2010, 24(1): 16-25.
Citation: Joshua M. Mutiso, John C. Macharia, Michael M. Gicheru. A review of adjuvants for Leishmania vaccine candidates[J]. The Journal of Biomedical Research, 2010, 24(1): 16-25.

A review of adjuvants for Leishmania vaccine candidates

More Information
  • Over the last decade, there has been a flurry of research on adjuvants for vaccines, and several novel adjuvants are now licensed products or in late stage clinical development. The success of adjuvants in enhancing the immune response to antigens has led many researchers to re-focus their vaccine development programs. Although several vaccine candidates have been tested against leishmaniasis, there is yet no effective vaccine against this parasitic disease. Recent research has documented that efforts to develop effective Leishmania vaccine have been limited due to lack of an appropriate adjuvant. In view of this, this review paper outlines some of the adjuvants that have been used in Leishmania vaccine candidates and cites a few of the responses obtained from these studies. The aim of the present review is to consolidate these findings to facilitate the application of these adjuvants in general and experimental vaccinology.
  • Related Articles

    [1]Izzatullo Ziyoyiddin o`g`li Abdullaev, Ulugbek Gapparjanovich Gayibov, Sirojiddin Zoirovich Omonturdiev, Sobirova Fotima Azamjonovna, Sabina Narimanovna Gayibova, Takhir Fatikhovich Aripov. Molecular pathways in cardiovascular disease under hypoxia: Mechanisms, biomarkers, and therapeutic targets[J]. The Journal of Biomedical Research. DOI: 10.7555/JBR.38.20240387
    [2]Liu Zhi, Wang Jianwei, Ge Yiyue, Xu Yuyu, Guo Mengchen, Mi Kai, Xu Rui, Pei Yang, Zhang Qiankun, Luan Xiaoting, Hu Zhibin, Chi Ying, Liu Xingyin. SARS-CoV-2 encoded microRNAs are involved in the process of virus infection and host immune response[J]. The Journal of Biomedical Research, 2021, 35(3): 216-227. DOI: 10.7555/JBR.35.20200154
    [3]Yu Xinyu, Wu Yuan, Zhang Jiarong, Jirimutu, Zulipikaer Azhati, Chen Jin. Pre-evaluation of humoral immune response of Bactrian camels by the quantification of Th2 cytokines using real-time PCR[J]. The Journal of Biomedical Research, 2020, 34(5): 387-394. DOI: 10.7555/JBR.34.20190035
    [4]Huijeong Ahn, Hyuk Moo Kwon, Eunsong Lee, Pyeung-Hyeun Kim, Eui-Bae Jeung, GeunShik Lee. Role of inflammasome regulation on immune modulators[J]. The Journal of Biomedical Research, 2018, 32(6): 401-410. DOI: 10.7555/JBR.32.20170120
    [5]Christopher J. Danford, Zemin Yao, Z. Gordon Jiang. Non-alcoholic fatty liver disease: a narrative review of genetics[J]. The Journal of Biomedical Research, 2018, 32(6): 389-400. DOI: 10.7555/JBR.32.20180045
    [6]Sukhbir Kaur, Tejinder Kaur, Jyoti Joshi. Immunogenicity and protective efficacy of DNA vaccine against visceral leishmaniasis in BALB/c mice[J]. The Journal of Biomedical Research, 2016, 30(4): 304-313. DOI: 10.7555/JBR.30.20150125
    [7]Yu Fang, Zou Xiang. Roles and relevance of mast cells in infection and vaccination[J]. The Journal of Biomedical Research, 2016, 30(4): 253-263. DOI: 10.7555/JBR.30.20150038
    [8]Samuel W. Mwololo, Joshua M. Mutiso, John C. Macharia, Alain J. Bourdichon, Michael M. Gicheru. In vitro activity and in vivo efficacy of a combination therapy of diminazene and chloroquine against murine visceral leishmaniasis[J]. The Journal of Biomedical Research, 2015, 29(3): 214-223. DOI: 10.7555/JBR.29.20140072
    [9]Joshua Muli Mutiso, John Chege Macharia, Maria Ndunge Kiio, James Maina Ichagichu, Hitler Rikoi, Michael Muita Gicheru. Development of Leishmania vaccines: predicting the future from past and present experience[J]. The Journal of Biomedical Research, 2013, 27(2): 85-102. DOI: 10.7555/JBR.27.20120064
    [10]Joshua Muli Mutiso, John Chege Macharia, Evans Taracha, Michael Muita Gicheru. Leishmania donovani whole cell antigen delivered with adjuvants protects against visceral leishmaniasis in vervet monkeys (Chlorocebus aethiops)[J]. The Journal of Biomedical Research, 2012, 26(1): 8-16. DOI: 10.1016/S1674-8301(12)60002-5

Catalog

    Article Metrics

    Article views (3247) PDF downloads (1212) Cited by()
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return